A better understanding of the mechanisms underlying cognitive impairment in schizophrenia is imperative, as it causes poor functional outcomes and a lack of effective treatments.
Aims:
This study aimed to investigate the relationships of two proposed main pathophysiology of schizophrenia, altered prefrontal–striatal connectivity and the dopamine system, with cognitive impairment and their interactions.
Methods:
Thirty-three patients with schizophrenia and 27 healthy controls (HCs) who are right-handed and matched for age and sex were recruited. We evaluated their cognition, functional connectivity (FC) between the dorsolateral prefrontal cortex (DLPFC)/middle frontal gyrus (MiFG) and striatum, and the availability of striatal dopamine transporter (DAT) using a cognitive battery investigating attention, memory, and executive function, resting-state functional magnetic resonance imaging with group independent component analysis and single-photon emission computed tomography with 99mTc-TRODAT.
Results:
Patients with schizophrenia exhibited poorer cognitive performance, reduced FC between DLPFC/MiFG and the caudate nucleus (CN) or putamen, decreased DAT availability in the left CN, and decreased right–left DAT asymmetry in the CN compared to HCs. In patients with schizophrenia, altered imaging markers are associated with cognitive impairments, especially the relationship between DLPFC/MiFG–putamen FC and attention and between DAT asymmetry in the CN and executive function.
Conclusions:
This study is the first to demonstrate how prefrontal–striatal hypoconnectivity and altered striatal DAT markers are associated with different domains of cognitive impairment in schizophrenia. More research is needed to evaluate their complex relationships and potential therapeutic implications.
AllenEErhardtEDamarajuE, et al. (2011) A baseline for the multivariate comparison of resting-state networks. Front Syst Neurosci5: 2.
2.
AnhøjSØdegaard NielsenMJensenMH, et al. (2018) Alterations of intrinsic connectivity networks in antipsychotic-naïve first-episode schizophrenia. Schizophr Bull44: 1332–1340.
3.
AvramMBrandlFBäumlJ, et al. (2018) Cortico-thalamic hypo- and hyperconnectivity extend consistently to basal ganglia in schizophrenia. Neuropsychopharmacology43: 2239–2248.
4.
AvramMBrandlFKnolleF, et al. (2020) Aberrant striatal dopamine links topographically with cortico-thalamic dysconnectivity in schizophrenia. Brain143: 3495–3505.
5.
BaikKChaJHamJH, et al. (2014) Dopaminergic modulation of resting-state functional connectivity in de novo patients with Parkinson’s disease. Hum Brain Mapp35: 5431–5441.
6.
BrakowskiJManoliuAHomanP, et al. (2022) Aberrant striatal coupling with default mode and central executive network relates to self-reported avolition and anhedonia in schizophrenia. J Psychiatr Res145: 263–275.
7.
BruggerSPAngelescuIAbi-DarghamA, et al. (2020) Heterogeneity of striatal dopamine function in schizophrenia: Meta-analysis of variance. Biol Psychiatry87: 215–224.
8.
BurnhamKPAndersonDR (2004) Multimodel inference: Understanding AIC and BIC in model selection. Sociol Methods Res33: 261–304.
9.
ChouY-HHunagW-SHsuJ-W, et al. (2010) Simultaneous measurement of dopamine transporters and D2/D3 receptors in drug naive schizophrenic patients. Clin Psychopharmacol Neurosci8: 97–104.
10.
ChungSJYooHSOhJS, et al. (2018) Effect of striatal dopamine depletion on cognition in de novo Parkinson’s disease. Parkinsonism Relat Disord51: 43–48.
11.
ConioBMartinoMMagioncaldaP, et al. (2020) Opposite effects of dopamine and serotonin on resting-state networks: Review and implications for psychiatric disorders. Mol Psychiatry25: 82–93.
12.
CostanzaAVasileiosCAmbrosettiJ, et al. (2022) Demoralization in suicide: A systematic review. J Psychosom Res157: 110788.
13.
CowmanMHolleranLLonerganE, et al. (2021) Cognitive predictors of social and occupational functioning in early psychosis: A systematic review and meta-analysis of cross-sectional and longitudinal data. Schizophr Bull47: 1243–1253.
14.
CrowTJ (2004) Cerebral asymmetry and the lateralization of language: Core deficits in schizophrenia as pointers to the gene. Curr Opin Psychiatry17: 97–106.
15.
DandashOPantelisCFornitoA (2017) Dopamine, fronto-striato-thalamic circuits and risk for psychosis. Schizophr Res180: 48–57.
16.
DattaDArnstenAFT (2018) Unique molecular regulation of higher-order prefrontal cortical circuits: Insights into the neurobiology of schizophrenia. ACS Chem Neurosci9: 2127–2145.
17.
DuYFuZSuiJ, et al. (2020) NeuroMark: An automated and adaptive ICA based pipeline to identify reproducible fMRI markers of brain disorders. Neuroimage Clin28: 102375.
18.
DuYPearlsonGDLiuJ, et al. (2015) A group ICA based framework for evaluating resting fMRI markers when disease categories are unclear: Application to schizophrenia, bipolar, and schizoaffective disorders. Neuroimage122: 272–280.
19.
Erixon-LindrothNFardeLRobins WahlinT-B, et al. (2005) The role of the striatal dopamine transporter in cognitive aging. Psychiatry Res138: 1–12.
20.
EstebanOBirmanDSchaerM, et al. (2017) MRIQC: Advancing the automatic prediction of image quality in MRI from unseen sites. PLoS One12: e0184661.
21.
EstebanOMarkiewiczCJBlairRW, et al. (2019) fMRIPrep: A robust preprocessing pipeline for functional MRI. Nat Methods16: 111–116.
22.
FornitoAHarrisonBJGoodbyE, et al. (2013) Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis. JAMA Psychiatry70: 1143–1151.
23.
GreenMFHoranWPLeeJ (2019) Nonsocial and social cognition in schizophrenia: Current evidence and future directions. World Psychiatry18: 146–161.
24.
HanSBeckerBDuanX, et al. (2020) Distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy. Schizophr Res215: 89–96.
25.
HareSMFordJMMathalonDH, et al. (2019) Salience–default mode functional network connectivity linked to positive and negative symptoms of schizophrenia. Schizophr Bull45: 892–901.
26.
HareSMLawASFordJM, et al. (2018) Disrupted network cross talk, hippocampal dysfunction and hallucinations in schizophrenia. Schizophr Res199: 226–234.
27.
HarveyPDBosiaMCavallaroR, et al. (2022) Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art. Schizophr Res Cogn29: 100249.
28.
HowesODKambeitzJKimE, et al. (2012) The nature of dopamine dysfunction in schizophrenia and what this means for treatment: Meta-analysis of imaging studies. Arch Gen Psychiatry69: 776–786.
29.
HsiaoM-CLinK-JLiuC-Y, et al. (2003) Dopamine transporter change in drug-naïve schizophrenia: An imaging study with 99mTc-TRODAT-1. Schizophr Res65: 39–46.
30.
JafriMJPearlsonGDStevensM, et al. (2008) A method for functional network connectivity among spatially independent resting-state components in schizophrenia. Neuroimage39: 1666–1681.
31.
JoelSECaffoBSvan ZijlPCM, et al. (2011) On the relationship between seed-based and ICA-based measures of functional connectivity. Magn Reson Med66: 644–657.
32.
JungJLambon RalphMAJacksonRL (2022) Subregions of DLPFC display graded yet distinct structural and functional connectivity. J Neurosci42: 3241–3252.
33.
KaiserRHTreadwayMTWootenDW, et al. (2018) Frontostriatal and dopamine markers of individual differences in reinforcement learning: A multi-modal investigation. Cereb Cortex28: 4281–4290.
34.
KimSJungWHHowesOD, et al. (2019) Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: An [18F]DOPA PET and fMRI study. Psychol Med49: 2533–2542.
35.
LaaksoABergmanJHaaparantaM, et al. (2001) Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res52: 115–120.
36.
LaaksoAVilkmanHAlakareB, et al. (2000) Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. Am J Psychiatry157: 269–271.
37.
LeeKJLeeJSKimSJ, et al. (2008) Loss of asymmetry in D2 receptors of putamen in unaffected family members at increased genetic risk for schizophrenia. Acta Psychiatr Scand118: 200–208.
38.
LeuchtSSamaraMHeresS, et al. (2016) Dose equivalents for antipsychotic drugs: The DDD method. Schizophr Bull42(Suppl 1): S90–S94.
39.
LewandowskiKEMcCarthyJMÖngürD, et al. (2019) Functional connectivity in distinct cognitive subtypes in psychosis. Schizophr Res204: 120–126.
40.
LinW-CChenH-LHsuT-W, et al. (2017) Correlation between dopamine transporter degradation and striatocortical network alteration in Parkinson’s disease. Front Neurol8: 323.
41.
MateosJJLomeñaFParelladaE, et al. (2007) Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait. Psychopharmacology191: 805–811.
MolochnikovICohenD (2014) Hemispheric differences in the mesostriatal dopaminergic system. Front Syst Neurosci8: 110.
44.
NourMMDahounTMcCutcheonRA, et al. (2019) Task-induced functional brain connectivity mediates the relationship between striatal D2/3 receptors and working memory. eLife8: e45045.
45.
NybergLKaralijaNSalamiA, et al. (2016) Dopamine D2 receptor availability is linked to hippocampal–caudate functional connectivity and episodic memory. Proc Natl Acad Sci U S A113: 7918–7923.
46.
OhSKimMKimT, et al. (2020) Resting-state functional connectivity of the striatum predicts improvement in negative symptoms and general functioning in patients with first-episode psychosis: A 1-year naturalistic follow-up study. Aust N Z J Psychiatry54: 509–518.
47.
ParkesLFulcherBYücelM, et al. (2018) An evaluation of the efficacy, reliability, and sensitivity of motion correction strategies for resting-state functional MRI. Neuroimage171: 415–436.
48.
PetersHRiedlVManoliuA, et al. (2017) Changes in extra-striatal functional connectivity in patients with schizophrenia in a psychotic episode. Br J Psychiatry210: 75–82.
49.
RaiserTMFlanaginVLDueringM, et al. (2020) The human corticocortical vestibular network. Neuroimage223: 117362.
50.
RiedlVUtzLCastrillónG, et al. (2016) Metabolic connectivity mapping reveals effective connectivity in the resting human brain. Proc Natl Acad Sci U S A113: 428–433.
51.
SabaroedinKRaziAChopraS, et al. (2023) Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuum. Brain146: 372–386.
52.
SarpalDKRobinsonDGFalesC, et al. (2017) Relationship between duration of untreated psychosis and intrinsic corticostriatal connectivity in patients with early phase schizophrenia. Neuropsychopharmacology42: 2214–2221.
53.
SekiguchiHPaveyGDeanB (2019) Altered levels of dopamine transporter in the frontal pole and dorsal striatum in schizophrenia. NPJ Schizophr5: 20.
54.
SerafiniGAdavastroGCanepaG, et al. (2017) Abnormalities in kynurenine pathway metabolism in treatment-resistant depression and suicidality: A systematic review. CNS Neurol Disord Drug Targets16: 440–453.
55.
ShangC-YLinH-YGauSS-F (2021) Effects of the dopamine transporter gene on striatal functional connectivity in youths with attention-deficit/hyperactivity disorder. Psychol Med51: 835–845.
56.
SheffieldJMBarchDM (2016) Cognition and resting-state functional connectivity in schizophrenia. Neurosci Biobehav Rev61: 108–120.
57.
SinkeviciuteIBegemannMPrikkenM, et al. (2018) Efficacy of different types of cognitive enhancers for patients with schizophrenia: A meta-analysis. NPJ Schizophr4: 22.
58.
SmucnyJDienelSJLewisDA, et al. (2022) Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia. Neuropsychopharmacology47: 292–308.
59.
SuT-WLanT-HHsuT-W, et al. (2013) Reduced neuro-integration from the dorsolateral prefrontal cortex to the whole brain and executive dysfunction in schizophrenia patients and their relatives. Schizophr Res148: 50–58.
60.
TakanoH (2018) Cognitive function and monoamine neurotransmission in schizophrenia: Evidence from positron emission tomography studies. Front Psychiatry9: 228.
61.
TuP-CHsiehJ-CLiC-T, et al. (2012) Cortico-striatal disconnection within the cingulo-opercular network in schizophrenia revealed by intrinsic functional connectivity analysis: A resting fMRI study. Neuroimage59: 238–247.
62.
Valdes-SosaPARoebroeckADaunizeauJ, et al. (2011) Effective connectivity: Influence, causality and biophysical modeling. Neuroimage58: 339–361.
63.
van DyckCHSeibylJPMalisonRT, et al. (2002) Age-related decline in dopamine transporters: Analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry10: 36–43.
64.
WeiS-YTsengH-HChangHH, et al. (2020) Dysregulation of oxytocin and dopamine in the corticostriatal circuitry in bipolar II disorder. Transl Psychiatry10: 281.
65.
WhiteTPWigtonRJoyceDW, et al. (2016) Dysfunctional striatal systems in treatment-resistant schizophrenia. Neuropsychopharmacology41: 1274–1285.
66.
Whitfield-GabrieliSNieto-CastanonA (2012) Conn: A functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect2: 125–141.
67.
WuC-HYangB-HChouY-H, et al. (2018a) Effects of 99mTc-TRODAT-1 drug template on image quantitative analysis. PLoS One13: e0194503.
68.
WuLCaprihanABustilloJ, et al. (2018b) An approach to directly link ICA and seed-based functional connectivity: Application to schizophrenia. Neuroimage179: 448–470.
69.
YamamotoMKushimaISuzukiR, et al. (2018) Aberrant functional connectivity between the thalamus and visual cortex is related to attentional impairment in schizophrenia. Psychiatry Res278: 35–41.
70.
YangK-CChenY-YLiuM-N, et al. (2022a) Interactions between dopamine transporter and N-methyl-d-aspartate receptor-related amino acids on cognitive impairments in schizophrenia. Schizophr Res248: 263–270.
71.
YangK-CHsiehW-CChouY-H (2022b) Cognitive factor structure and measurement invariance between healthy controls and patients with major depressive disorder. J Psychiatr Res151: 598–605.
72.
YangK-CLiuM-NLiouY-J, et al. (2021) Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study. J Psychiatr Res135: 174–180.
73.
YangK-CLiuM-NYangB-H, et al. (2022c) Role of dopamine transporter in the hrelationship between plasma cortisol and cognition. Psychosom Med84: 685–694.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
